Konstantinos Arfanakis1,2,3, Arnold M Evia1, Sue E Leurgans2,4, Luis F C Cardoso1, Arman Kulkarni1, Nabil Alqam1, Lucas F Lopes1, Diego Vieira1, David A Bennett2,4, Julie A Schneider2,4,5. 1. Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA. 2. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. 3. Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA. 4. Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA. 5. Department of Pathology, Rush University Medical Center, Chicago, IL, USA.
Abstract
BACKGROUND: The association of white matter hyperintensities (WMH) with age-related vascular and neurodegenerative pathologies remains incompletely understood. OBJECTIVE: The objective of this work was to elucidate the neuropathologic correlates of WMH in a large community-based cohort of older adults. METHODS: Cerebral hemispheres from 603 community-based older adults were imaged with MRI ex vivo. All participants underwent annual clinical evaluation, cognitive assessment, and neuropathologic examination. WMH burden was assessed using a modified Fazekas rating scale. Multiple ordinal logistic regression was used to test the association of WMH burden with an array of age-related neuropathologies, adjusting for demographics. Mixed effects models of cognition controlling for neuropathologies and demographics were used to determine whether WMH burden contributes to cognitive decline beyond measured pathologies. RESULTS: WMH burden in the whole group was associated with both vascular and Alzheimer's disease (AD) pathologies: arteriolosclerosis (p < 10-4), gross (p < 10-4), and microscopic infarcts (p = 0.04), and amyloid-β plaques (p = 0.028). In non-demented participants (mild or no cognitive impairment) (N = 332), WMH burden was related to gross infarcts (p = 10-4) and arteriolosclerosis (p < 10-4), but not to AD pathology. Similarly, in those with no cognitive impairment (N = 178), WMH burden was related to gross infarcts (p = 8×10-4) and arteriolosclerosis (p = 0.014). WMH burden was associated with faster decline in perceptual speed in both the whole (p = 0.038) and non-demented (p = 0.006) groups. CONCLUSION: WMH burden has independent associations with vascular pathologies in older adults regardless of clinical status, and with AD pathology later in the progression of AD. Moreover, WMH burden may reflect additional tissue injury not captured with traditional neuropathologic indices.
BACKGROUND: The association of white matter hyperintensities (WMH) with age-related vascular and neurodegenerative pathologies remains incompletely understood. OBJECTIVE: The objective of this work was to elucidate the neuropathologic correlates of WMH in a large community-based cohort of older adults. METHODS: Cerebral hemispheres from 603 community-based older adults were imaged with MRI ex vivo. All participants underwent annual clinical evaluation, cognitive assessment, and neuropathologic examination. WMH burden was assessed using a modified Fazekas rating scale. Multiple ordinal logistic regression was used to test the association of WMH burden with an array of age-related neuropathologies, adjusting for demographics. Mixed effects models of cognition controlling for neuropathologies and demographics were used to determine whether WMH burden contributes to cognitive decline beyond measured pathologies. RESULTS:WMH burden in the whole group was associated with both vascular and Alzheimer's disease (AD) pathologies: arteriolosclerosis (p < 10-4), gross (p < 10-4), and microscopic infarcts (p = 0.04), and amyloid-β plaques (p = 0.028). In non-demented participants (mild or no cognitive impairment) (N = 332), WMH burden was related to gross infarcts (p = 10-4) and arteriolosclerosis (p < 10-4), but not to AD pathology. Similarly, in those with no cognitive impairment (N = 178), WMH burden was related to gross infarcts (p = 8×10-4) and arteriolosclerosis (p = 0.014). WMH burden was associated with faster decline in perceptual speed in both the whole (p = 0.038) and non-demented (p = 0.006) groups. CONCLUSION:WMH burden has independent associations with vascular pathologies in older adults regardless of clinical status, and with AD pathology later in the progression of AD. Moreover, WMH burden may reflect additional tissue injury not captured with traditional neuropathologic indices.
Entities:
Keywords:
Cognition; magnetic resonance imaging; pathology; white matter zzm321990hyperintensities
Authors: Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Jonathan Graff-Radford; Eider M Arenaza-Urquijo; David S Knopman; Christopher G Schwarz; Robert D Brown; Alejandro A Rabinstein; Jeffrey L Gunter; Matthew L Senjem; Scott A Przybelski; Timothy Lesnick; Chadwick Ward; Michelle M Mielke; Val J Lowe; Ronald C Petersen; Walter K Kremers; Kejal Kantarci; Clifford R Jack; Prashanthi Vemuri Journal: Brain Date: 2019-08-01 Impact factor: 13.501
Authors: Ewoud J van Dijk; Niels D Prins; Henri A Vrooman; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: Stroke Date: 2008-07-17 Impact factor: 7.914
Authors: David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Zoe Arvanitakis; Debra A Fleischman; Konstantinos Arfanakis; Sue E Leurgans; Lisa L Barnes; David A Bennett Journal: Brain Struct Funct Date: 2015-04-02 Impact factor: 3.270
Authors: Julia A Scott; Meredith N Braskie; Duygu Tosun; Paul M Thompson; Michael Weiner; Charles DeCarli; Owen T Carmichael Journal: Front Aging Neurosci Date: 2015-12-01 Impact factor: 5.750
Authors: Patricia A Boyle; Lei Yu; Debra A Fleischman; Sue Leurgans; Jingyun Yang; Robert S Wilson; Julie A Schneider; Zoe Arvanitakis; Konstantinos Arfanakis; David A Bennett Journal: Ann Clin Transl Neurol Date: 2016-09-01 Impact factor: 4.511
Authors: Madeline Uretsky; Sylvain Bouix; Ronald J Killiany; Yorghos Tripodis; Brett Martin; Joseph Palmisano; Asim Z Mian; Karen Buch; Chad Farris; Daniel H Daneshvar; Brigid Dwyer; Lee Goldstein; Douglas Katz; Christopher Nowinski; Robert Cantu; Neil Kowall; Bertrand Russell Huber; Robert A Stern; Victor E Alvarez; Thor D Stein; Ann McKee; Jesse Mez; Michael L Alosco Journal: Neurology Date: 2021-11-24 Impact factor: 9.910
Authors: Ahmed Abdelhak; Isaac Solomon; Shivany Condor Montes; Alexandra Saias; Christian Cordano; Breton Asken; Corrina Fonseca; Frederike Cosima Oertel; Konstantinos Arfanakis; Adam M Staffaroni; Joel H Kramer; Michael Geschwind; Bruce L Miller; Fanny M Elahi; Ari J Green Journal: Alzheimers Dement (Amst) Date: 2022-07-05
Authors: Gloria C Chiang; Junghun Cho; Jonathan Dyke; Hang Zhang; Qihao Zhang; Michael Tokov; Thanh Nguyen; Ilhami Kovanlikaya; Michael Amoashiy; Mony de Leon; Yi Wang Journal: J Neuroimaging Date: 2022-03-16 Impact factor: 2.324
Authors: Debra A Fleischman; Konstantinos Arfanakis; Sue E Leurgans; Shengwei Zhang; Victoria N Poole; S Duke Han; Lei Yu; Melissa Lamar; Namhee Kim; David A Bennett; Lisa L Barnes Journal: Neurobiol Aging Date: 2021-11-20 Impact factor: 5.133
Authors: Namhee Kim; Konstantinos Arfanakis; Sue E Leurgans; Jingyun Yang; Debra A Fleischman; S Duke Han; Neelum T Aggarwal; Melissa Lamar; Lei Yu; Victoria N Poole; David A Bennett; Lisa L Barnes Journal: J Neurosci Methods Date: 2021-05-27 Impact factor: 2.987
Authors: Shahram Oveisgharan; Lei Yu; Lisa L Barnes; Sonal Agrawal; Julie A Schneider; David A Bennett; Aron S Buchman Journal: Neurology Date: 2022-03-23 Impact factor: 11.800